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Abstract  I  report  a  case  of  hypotension  and  bradycardia  before  spinal  anesthesia  in  a  pregnant
woman with  mild  to  moderate  hypertension  treated  with  nifedipine  and  methyldopa,  scheduled
for an  elective  cesarean  delivery.  She  had  the  history  of  neurally-mediated  syncopes.  Two  main
factors (increased  vagal  tone  and  adverse  effects  of  antihypertensive  drugs)  could  explain  the
hypotension  and  bradycardia  before  spinal  anesthesia.  Monitoring  allowed  recognizing  the  prob-
lem and  corrected  it.  Thus,  it  was  avoided  a  disaster  in  anesthesia,  as  hemodynamic  changes
after spinal  anesthesia,  they  would  have  joined  to  previous  hypotension  and  bradycardia,  which
would have  caused  even  a  cardiac  arrest.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Hipotensão  e  bradicardia  antes  da  raquianestesia
Resumo  Relato  de  um  caso  de  hipotensão  e  bradicardia  antes  da  raquianestesia  em  uma
mulher grávida  com  hipertensão  leve  a  moderada  tratada  com  nifedipina  e  metildopa,  pro-
gramada para  parto  cesário  eletivo.  A  paciente  apresentava  história  de  síncopes  neuralmente
mediadas.  Dois  fatores  principais  (aumento  do  tônus  vagal  e  efeitos  adversos  de  medicamentos
anti-hipertensivos)  poderiam  explicar  a  hipotensão  e  bradicardia  antes  da  raquianestesia.  O
monitoramento  permitiu  reconhecer  o  problema  e  corrigi-lo.  Assim,  foi  evitado  um  desastre
em anestesia;  assim  como  as  alterac¸ões  hemodinâmicas  após  a  raquianestesia,  esses  fatores
teriam se  juntado  à  hipotensão  e  bradicardia  anterior,  o  que  poderia  ter  causado  inclusive  uma
parada cardíaca.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Please  cite  this  article  in  press  as:  Shiraishi  Zapata  CJ.  Hypote
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2014.12.0
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ntroduction
 wide  range  of  antihypertensive  drugs  have  been  proposed
o  decrease  the  blood  pressure  in  hypertensive  pregnant
omen,  and  each  of  them  has  different  side  effects  and
otential  adverse  effects.  There  is  no  consensus  about  the
eﬁnition  of  hypertensive  pregnancy  disorders  and  several
lassiﬁcations  have  been  suggested.  Variations  in  the  sys-
ems  for  classiﬁcation  are  largely  according  to  which  values
f  blood  pressure  are  considered  abnormal.  Nevertheless,
here  is  currently  an  agreement  regarding  the  existence  of
our  categories  which  include  gestational  hypertension  or
regnancy-induced  hypertension.1
A  case  of  hypotension  and  bradycardia  before  spinal
nesthesia  in  a  pregnant  woman  with  mild  to  moderate
ypertension,  scheduled  for  an  elective  cesarean  delivery,
s  reported  with  the  patient’s  and  the  Hospital  Ethics  Com-
ittee’s  written  consent.
ase report
 34-year-old  patient  was  admitted  four  days  before  surgery,
ith  a  gestational  age  of  37  weeks  by  date  of  last  men-
truation  and  pregnancy-induced  hypertension.  She  had  two
revious  Caesarian  sections  (in  2007  and  2011)  which  were
erformed  with  spinal  anesthesia  without  complications.
he  was  suffering  from  intermittent  bronchial  asthma,  with
 ﬁnal  episode  in  the  year  2013;  and  reported  some  episodes
f  vasovagal  and  orthostatic  syncopes  in  different  times  of
er  life.  Her  weight  and  height  were  98.8  kg  and  1.65  m,
espectively.  Her  physical  condition  was  grade  2  according
o  American  Society  Anesthesiologists  physical  status  clas-
iﬁcation;  she  was  assigned  to  class  2  of  Goldman  index
f  cardiac  risk  and  had  a  normal  electrocardiogram.  The
aboratory  analyses  showed  a  hemogram  with  normal  val-
es  (hematocrit  41%,  platelets  237,000  mm3);  the  values  of
lucose,  creatinine,  urea,  and  aminotransferases  were  nor-
al  too.  The  value  of  proteins  in  a  24  h  urine  was  126  mg
3000  mL  of  urinary  volume).
When  the  patient  was  hospitalized,  four  days  before  the
urgery,  her  blood  pressure  was  140/80  mmHg  and  the  heart
ate  (HR)  was  79  beats  per  minute  (bpm).  An  antihyper-
ensive  treatment  of  10  mg  of  nifedipine  was  administered
rally  t.i.d.  A  day  later  was  added  methyldopa  500  mg  orally
.i.d.  She  swallowed  food  until  5  p.m.  and  received  the  last
ose  of  antihypertensive  drugs  up  to  22  h  of  the  previous  day
o  the  cesarean  section.
The  day  of  surgery  the  patient  did  not  receive  antihy-
ertensive  treatment,  and  the  last  control  of  vital  signs
t  7  a.m.  was  registered  as  normal  in  the  hospitalization
rea.  Furthermore,  she  received  a  bolus  of  physiologi-
al  saline  serum  (500  mL).  None  of  the  previous  controls
f  blood  pressure  was  lesser  than  110/70  mmHg  until
wo  days  before  the  cesarean  section.  However  the  day
efore,  she  registered  a  blood  pressure  of  90/60  mmHg  at
 p.m.
When  the  patient  entered  the  operating  room  at  9:40Please  cite  this  article  in  press  as:  Shiraishi  Zapata  CJ.  Hypote
Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2014.12.
.m.,  she  was  lucid  and  oriented;  nevertheless,  paleness  and
nxiety  were  observed.  A  non-invasive  blood  pressure  (NIBP)
f  73/35  mmHg  was  measured  in  the  multi-parameters  mon-
tor,  HR  of  37  bpm  and  a  breathing  rate  of  18  breaths  per
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inute.  The  results  were  corroborated  by  manual  mea-
urements.  The  patient  was  asked  if  she  had  taken  some
edicine  which  she  denied.
The  patient  received  an  infusion  of  500  mL  of  isotonic
aline  solution;  next  a NIBP  of  80/42  mmHg  was  measured.
fter  she  was  given  1000  mL,  her  NIBP  was  92/64  mmHg.
inally,  she  gave  a  volume  of  1500  mL  and  her  blood  pressure
ose  to  110/60  mmHg.  Atropine  (0.5  mg)  was  given  intra-
enously,  which  made  her  HR  go  up  to  82  bpm.  At  10  am,  I
roceeded  to  administer  spinal  anesthesia  containing  10  mg
f  hyperbaric  Bupivacaine  and  10  gr  of  fentanyl,  at  the
evel  of  the  L3--L4  space  with  needle  type  Quincke  no.  26.
e  placed  the  patient  in  dorsal  decubitus  with  15◦ of  left
nclination  from  the  surgical  table.  Fifteen  minutes  after,
he  surgery  started  with  a NIBP  of  90/42  mmHg  and  HR  of
14  bpm.  Ten  minutes  after  there  was  the  birth  of  the  fetus
ith  good  Apgar  scores;  in  this  time  it  was  controlled  a  NIBP
f  79/40  mmHg,  so  I  started  intravenous  infusion  of  3  mg  of
tilefrine  and  two  bolus  of  1  mg  of  the  same  drug  with  that
he  NIBP  rose  to  130/60  mmHg.
No  other  problems  occurred  in  the  remaining  period  of
he  surgery.  The  patient  left  at  11:05  with  isotonic  saline
olution  (total  infused  volume  of  2500  mL)  and  20  IU  of  Oxy-
ocin  infused  intravenously,  without  any  kind  of  vasopressor,
IBP  of  114/64  mmHg,  HR  99  bpm,  oxygen  saturation  on
oom  air  96%  and  breathing  rate  of  16  bpm.
iscussion
hen  I  investigated  the  causes  of  hypotension  and  bradycar-
ia  at  the  entrance  to  the  operating  room,  anaphylaxis  was
iscarded  ﬁrst,  because  it  has  not  had  provided  any  medica-
ion  before  operating  room;  then,  was  considered  an  excess
agal  because  she  had  had  some  episodes  of  transient  loss
f  consciousness  tone,  even  though  she  was  aware  when  she
rrived  to  the  operating  room.  Nonetheless,  there  are  some
nteresting  points  about  the  adverse  effects  of  antihyper-
ensive  drugs,  too.
Nifedipine,  as  calcium  antagonist  antihypertensive,  has
 short  terminal  half-life  of  1.9  h  for  a  10  mg  tablet,  so
ultiple  doses  are  required  to  achieve  the  effective  concen-
ration  (78  g/lt.);  being  the  minimum  concentration  to
ecrease  diastolic  pressure  of  10--15  g/lt.2 In  relation  to
rthostatic  syncopes,  it  has  been  described  four  causes  of
ompensatory  failure.  One  of  them  is  the  attenuation  of
asoconstrictor  response  to  sympathetic  stimulation;  this
ttenuated  response  is  primarily  caused  by  the  adminis-
ration  of  vasodilative  agents  among  which  are  calcium
ntagonists  as  nifedipine.3
Methyldopa  (-methyl-3,4-dihidroxi-l-phenylalanine),
nalog  of  3,4-dihydroxyphenylalanine  (DOPA)  discovered
n  1960  by  Oates,4 is  a  prodrug  of  central  action  that
cts  by  the  active  metabolite  -methylnorepinephrine
which  replaces  norepinephrine  in  the  secretory  vesicles
f  adrenergic  neurons).  It  causes  a  decrease  of  the  blood
ressure  which  is  a  maximum  of  6--8  h  after  an  oral  or
ntravenous  dose,  and  mitigates  but  does  not  block  com-nsion  and  bradycardia  before  spinal  anesthesia.  Rev  Bras
008
letely  baroreceptors-mediated  vasoconstriction.  For  this
eason,  is  tolerated  well  during  surgical  anesthesia  and  any
evere  hypotension  is  reversible  with  volume  expansion,  as
t  happened  with  the  management  of  this  pregnant  woman
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inside  the  operating  room.  Although  the  maximum  plasma
concentrations  occur  after  2--3  h,  the  maximum  effect  is
delayed  6--8  h,  and  a  single  dose  usually  lasts  almost  24  h,
which  allows  providing  a  dosage  one  to  two  times  per
day.5--7 Therefore,  in  this  case,  methyldopa  should  not  have
been  supplied  three  times  per  day  and  could  have  begun
with  one  lower  dose;  even  more  considering  that  she  was
already  receiving  nifedipine.
Among  the  most  common  adverse  effects  from  methyl-
dopa  include  fatigue,  xerostomia,  decreased  libido,  parkin-
sonian  signs,  hyperprolactinemia,  hepatotoxicity,  intense
bradycardia  and  sinoatrial  asystole,  sedation  and  even
depression  in  higher  doses.8,9 Hypotension  has  also  been
reported  as  frequent  adverse  effect,  especially  in  younger
patients,  lighter  subjects,  patients  with  impairment  of  renal
function  or  in  those  taking  high  daily  doses.10 However,  it  has
a  safety  proﬁle  in  the  treatment  of  gestational  hyperten-
sion,  currently  reaching  to  constitute  the  drug  of  choice  for
the  treatment  of  non-severe  hypertension  in  this  population,
used  in  different  regions  around  the  world.5,11--13
In  conclusion,  two  main  factors  can  be  observed  in  this
case,  in  one  side  a  history  of  increased  vagal  tone  of  the
patient  and  in  the  other,  the  adverse  effects  of  previous
medical  therapy.  Both  of  them  affected  the  planned  anes-
thetic  scheme  for  an  elective  surgery.  Monitoring  had  an
important  role  because  it  allowed  recognizing  the  problem
and  corrected  it.  Thus,  it  was  avoided  a  disaster  in  anes-
thesia,  as  hemodynamic  changes  that  occur  after  a  spinal
anesthesia  in  a  pregnant  woman,  they  would  have  joined
to  previous  hypotension  and  bradycardia,  which  probably
would  have  caused  even  a  cardiac  arrest.
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